Synopsis

Source of validity: Scientific
Rating (out of 5): 4

AMP-activated protein kinase (AMPK) is an enzyme that functions as a cellular energy sensor and is activated in response to low energy states. There is significant scientific interest in AMPK as a therapeutic target for obesity and weight management. Preclinical studies have shown that AMPK activation increases energy expenditure, promotes fatty acid oxidation, inhibits lipogenesis (fat creation), and suppresses appetite through central and peripheral mechanisms. Pharmacological activators of AMPK, such as metformin (commonly used in type 2 diabetes), have shown weight-lowering effects in both animal models and humans, though the weight loss is usually modest. Natural compounds, including berberine and resveratrol, have also been reported to activate AMPK, with some clinical trials suggesting mild weight reduction benefits.

However, translating these findings into consistent clinical outcomes for weight loss in humans has been challenging. While AMPK activation correlates with metabolic improvements, direct AMPK activators as standalone anti-obesity therapeutics are still under investigation, and no AMPK-specific drug is currently approved solely for weight loss. Nevertheless, the mechanism is well-characterized, and there is moderate-to-strong scientific validation that AMPK activation supports weight management, especially as part of a broader metabolic intervention. Thus, while AMPK is not a "weight loss supplement" per se, targeting this pathway is a scientifically grounded strategy for supporting weight loss efforts.

More about AMP-activated protein kinase (AMPK)
More about Weight Loss

Other ingredients used for Weight Loss

Other health conditions supported by AMP-activated protein kinase (AMPK)

Products containing AMP-activated protein kinase (AMPK)